Breast Cancer Research (Nov 2017)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study
- Olivier Brouckaert,
- Anja Rudolph,
- Annouschka Laenen,
- Renske Keeman,
- Manjeet K. Bolla,
- Qin Wang,
- Adelheid Soubry,
- Hans Wildiers,
- Irene L. Andrulis,
- Volker Arndt,
- Matthias W. Beckmann,
- Javier Benitez,
- Carl Blomqvist,
- Stig E. Bojesen,
- Hiltrud Brauch,
- Paul Brennan,
- Hermann Brenner,
- Georgia Chenevix-Trench,
- Ji-Yeob Choi,
- Sten Cornelissen,
- Fergus J. Couch,
- Angela Cox,
- Simon S. Cross,
- Kamila Czene,
- Mikael Eriksson,
- Peter A. Fasching,
- Jonine Figueroa,
- Henrik Flyger,
- Graham G. Giles,
- Anna González-Neira,
- Pascal Guénel,
- Per Hall,
- Antoinette Hollestelle,
- John L. Hopper,
- Hidemi Ito,
- Michael Jones,
- Daehee Kang,
- kConFab,
- Julia A. Knight,
- Veli-Matti Kosma,
- Jingmei Li,
- Annika Lindblom,
- Jenna Lilyquist,
- Artitaya Lophatananon,
- Arto Mannermaa,
- Siranoush Manoukian,
- Sara Margolin,
- Keitaro Matsuo,
- Kenneth Muir,
- Heli Nevanlinna,
- Paolo Peterlongo,
- Katri Pylkäs,
- Suleeporn Saajrang,
- Caroline Seynaeve,
- Chen-Yang Shen,
- Xiao-Ou Shu,
- Melissa C. Southey,
- Anthony Swerdlow,
- Soo-Hwang Teo,
- Rob A. E. M. Tollenaar,
- Thérèse Truong,
- Chiu-chen Tseng,
- Alexandra J. van den Broek,
- Carolien H. M. van Deurzen,
- Robert Winqvist,
- Anna H. Wu,
- Cheng Har Yip,
- Jyh-Cherng Yu,
- Wei Zheng,
- Roger L. Milne,
- Paul D. P. Pharoah,
- Douglas F. Easton,
- Marjanka K. Schmidt,
- Montserrat Garcia-Closas,
- Jenny Chang-Claude,
- Diether Lambrechts,
- Patrick Neven
Affiliations
- Olivier Brouckaert
- Department of Obstetrics and Gynaecology, Jan Yperman Hospital
- Anja Rudolph
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)
- Annouschka Laenen
- Centre for Biostatistics and Statistical Bioinformatics, KU Leuven
- Renske Keeman
- Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital
- Manjeet K. Bolla
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care University of Cambridge
- Qin Wang
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care University of Cambridge
- Adelheid Soubry
- Epidemiology Research Unit, Department of Public Health and Primary Care, Faculty of Medicine, KU Leuven - University of Leuven
- Hans Wildiers
- Department of Oncology, Leuven Multidisciplinary Breast Cancer, University Hospital Leuven, KU Leuven
- Irene L. Andrulis
- Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
- Volker Arndt
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)
- Matthias W. Beckmann
- Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN
- Javier Benitez
- Human Cancer Genetics Program, Spanish National Cancer Research Centre
- Carl Blomqvist
- Department of Oncology, Helsinki University Hospital, University of Helsinki
- Stig E. Bojesen
- Copenhagen General Population Study, Herlev and Gentofte Hospital, Copenhagen University Hospital
- Hiltrud Brauch
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
- Paul Brennan
- International Agency for Research on Cancer
- Hermann Brenner
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ)
- Georgia Chenevix-Trench
- Department of Genetics, QIMR Berghofer Medical Research Institute
- Ji-Yeob Choi
- Department of Biomedical Sciences, Seoul National University College of Medicine
- Sten Cornelissen
- Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital
- Fergus J. Couch
- Department of Laboratory Medicine and Pathology, Mayo Clinic
- Angela Cox
- Sheffield Cancer Research, Department of Oncology and Metabolism, University of Sheffield
- Simon S. Cross
- Academic Unit of Pathology, Department of Neuroscience, University of Sheffield
- Kamila Czene
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
- Mikael Eriksson
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
- Peter A. Fasching
- Department of Gynaecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN
- Jonine Figueroa
- Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh Medical School
- Henrik Flyger
- Department of Breast Surgery, Herlev and Gentofte Hospital, Copenhagen University Hospital
- Graham G. Giles
- Cancer Epidemiology & Intelligence Division, Cancer Council Victoria
- Anna González-Neira
- Human Cancer Genetics Program, Spanish National Cancer Research Centre
- Pascal Guénel
- Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay
- Per Hall
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
- Antoinette Hollestelle
- Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute
- John L. Hopper
- Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global health, The University of Melbourne
- Hidemi Ito
- Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
- Michael Jones
- Division of Genetics and Epidemiology, The Institute of Cancer Research
- Daehee Kang
- Department of Biomedical Sciences, Seoul National University College of Medicine
- kConFab
- kConFab, Research Department, Peter MacCallum Cancer Centre, and The Sir Peter MacCallum Department of Oncology, University of Melbourne
- Julia A. Knight
- Prosserman Centre for Health Research, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital
- Veli-Matti Kosma
- Cancer Center of Eastern Finland, University of Eastern Finland
- Jingmei Li
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet
- Annika Lindblom
- Department of Molecular Medicine and Surgery, Karolinska Institutet
- Jenna Lilyquist
- Department of Health Sciences Research, Mayo Clinic
- Artitaya Lophatananon
- Division of Health Sciences, Warwick Medical School, Warwick University
- Arto Mannermaa
- Cancer Center of Eastern Finland, University of Eastern Finland
- Siranoush Manoukian
- Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT)
- Sara Margolin
- Department of Oncology - Pathology, Karolinska Institutet
- Keitaro Matsuo
- Division of Molecular Medicine, Aichi Cancer Center Research Institute
- Kenneth Muir
- Division of Health Sciences, Warwick Medical School, Warwick University
- Heli Nevanlinna
- Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki
- Paolo Peterlongo
- IFOM, The FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology
- Katri Pylkäs
- Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu
- Suleeporn Saajrang
- National Cancer Institute
- Caroline Seynaeve
- Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute
- Chen-Yang Shen
- School of Public Health, China Medical University
- Xiao-Ou Shu
- Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
- Melissa C. Southey
- Department of Pathology, The University of Melbourne
- Anthony Swerdlow
- Division of Genetics and Epidemiology, The Institute of Cancer Research
- Soo-Hwang Teo
- Cancer Research Initiatives Foundation
- Rob A. E. M. Tollenaar
- Department of Surgery, Leiden University Medical Center
- Thérèse Truong
- Cancer & Environment Group, Center for Research in Epidemiology and Population Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay
- Chiu-chen Tseng
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California
- Alexandra J. van den Broek
- Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute
- Carolien H. M. van Deurzen
- Department of Pathology, Erasmus University Medical Center
- Robert Winqvist
- Laboratory of Cancer Genetics and Tumor Biology, Cancer and Translational Medicine Research Unit, Biocenter Oulu, University of Oulu
- Anna H. Wu
- Department of Preventive Medicine, Keck School of Medicine, University of Southern California
- Cheng Har Yip
- Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre
- Jyh-Cherng Yu
- Department of Surgery, National Taiwan University Hospital
- Wei Zheng
- Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
- Roger L. Milne
- Cancer Epidemiology & Intelligence Division, Cancer Council Victoria
- Paul D. P. Pharoah
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care University of Cambridge
- Douglas F. Easton
- Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care University of Cambridge
- Marjanka K. Schmidt
- Netherlands Cancer Institute, Antoni van Leeuwenhoek hospital
- Montserrat Garcia-Closas
- Division of Cancer Epidemiology and Genetics, National Cancer Institute
- Jenny Chang-Claude
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ)
- Diether Lambrechts
- Center for Cancer Biology, VIB
- Patrick Neven
- Department of Oncology, Leuven Multidisciplinary Breast Cancer, University Hospital Leuven, KU Leuven
- DOI
- https://doi.org/10.1186/s13058-017-0909-3
- Journal volume & issue
-
Vol. 19,
no. 1
pp. 1 – 12
Abstract
Abstract Background Previous studies have shown that reproductive factors are differentially associated with breast cancer (BC) risk by subtypes. The aim of this study was to investigate associations between reproductive factors and BC subtypes, and whether these vary by age at diagnosis. Methods We used pooled data on tumor markers (estrogen and progesterone receptor, human epidermal growth factor receptor-2 (HER2)) and reproductive risk factors (parity, age at first full-time pregnancy (FFTP) and age at menarche) from 28,095 patients with invasive BC from 34 studies participating in the Breast Cancer Association Consortium (BCAC). In a case-only analysis, we used logistic regression to assess associations between reproductive factors and BC subtype compared to luminal A tumors as a reference. The interaction between age and parity in BC subtype risk was also tested, across all ages and, because age was modeled non-linearly, specifically at ages 35, 55 and 75 years. Results Parous women were more likely to be diagnosed with triple negative BC (TNBC) than with luminal A BC, irrespective of age (OR for parity = 1.38, 95% CI 1.16–1.65, p = 0.0004; p for interaction with age = 0.076). Parous women were also more likely to be diagnosed with luminal and non-luminal HER2-like BCs and this effect was slightly more pronounced at an early age (p for interaction with age = 0.037 and 0.030, respectively). For instance, women diagnosed at age 35 were 1.48 (CI 1.01–2.16) more likely to have luminal HER2-like BC than luminal A BC, while this association was not significant at age 75 (OR = 0.72, CI 0.45–1.14). While age at menarche was not significantly associated with BC subtype, increasing age at FFTP was non-linearly associated with TNBC relative to luminal A BC. An age at FFTP of 25 versus 20 years lowered the risk for TNBC (OR = 0.78, CI 0.70–0.88, p < 0.0001), but this effect was not apparent at a later FFTP. Conclusions Our main findings suggest that parity is associated with TNBC across all ages at BC diagnosis, whereas the association with luminal HER2-like BC was present only for early onset BC.
Keywords
- Breast cancer subtype
- Age at breast cancer diagnosis
- Parity
- Age at first full-time pregnancy
- Age at menarche